JNE Partners LLP is required to file a 13D/G report to the SEC when the ownership of a company's total stock issue exceeds 5%.
Filed | Shares | Percentage | |
---|---|---|---|
Prevail Therapeutics Inc. | January 29, 2021 | ? | ? |
JNE Partners LLP is required to file a 13D/G report to the SEC when the ownership of a company's total stock issue exceeds 5%.
Filed | Shares | Percentage | |
---|---|---|---|
Prevail Therapeutics Inc. | January 29, 2021 | ? | ? |